Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126229681 | 12622968 | 1 | I | 20160727 | 20160804 | 20160804 | EXP | PHHY2016US105620 | SANDOZ | HOFFMANN MS, OVERMAN MJ, NATES JL.. ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMITANT ORAL OLANZAPINE. THE JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY. 2016;14 (4):178-9 | 61.00 | YR | F | Y | 0.00000 | 20160804 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126229681 | 12622968 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10 MG, QD | U | 201588 | 10 | MG | QD | ||||||
126229681 | 12622968 | 2 | I | OLANZAPINE. | OLANZAPINE | 1 | U | 201588 | |||||||||||
126229681 | 12622968 | 3 | I | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG,2-3 TIMES DAILY FOR SEVERAL MONTHS | U | 0 | 1 | MG | |||||||
126229681 | 12622968 | 4 | I | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 1 MG, UNK | U | 0 | 1 | MG | |||||||
126229681 | 12622968 | 5 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 60 MG/M2, UNK OVER 2 HOURS | U | 0 | 60 | MG/M**2 | |||||||
126229681 | 12622968 | 6 | C | OXALIPLATIN. | OXALIPLATIN | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 7 | C | OXALIPLATIN. | OXALIPLATIN | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 8 | C | OXALIPLATIN. | OXALIPLATIN | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 9 | C | 5 FLUORO URACIL | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 2000 MG/M2, UNK OVER 46 HOURS | U | 0 | 2000 | MG/M**2 | |||||||
126229681 | 12622968 | 10 | C | 5 FLUORO URACIL | FLUOROURACIL | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 11 | C | 5 FLUORO URACIL | FLUOROURACIL | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 12 | C | 5 FLUORO URACIL | FLUOROURACIL | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 13 | C | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
126229681 | 12622968 | 14 | C | FOLINIC ACID | LEUCOVORIN | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 15 | C | FOLINIC ACID | LEUCOVORIN | 1 | U | 0 | |||||||||||
126229681 | 12622968 | 16 | C | FOLINIC ACID | LEUCOVORIN | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126229681 | 12622968 | 1 | Vomiting |
126229681 | 12622968 | 2 | Nausea |
126229681 | 12622968 | 3 | Vomiting |
126229681 | 12622968 | 4 | Nausea |
126229681 | 12622968 | 5 | Pancreatic carcinoma |
126229681 | 12622968 | 6 | Metastases to lung |
126229681 | 12622968 | 7 | Metastases to liver |
126229681 | 12622968 | 8 | Metastases to lymph nodes |
126229681 | 12622968 | 9 | Pancreatic carcinoma |
126229681 | 12622968 | 10 | Metastases to lung |
126229681 | 12622968 | 11 | Metastases to liver |
126229681 | 12622968 | 12 | Metastases to lymph nodes |
126229681 | 12622968 | 13 | Pancreatic carcinoma |
126229681 | 12622968 | 14 | Metastases to lung |
126229681 | 12622968 | 15 | Metastases to liver |
126229681 | 12622968 | 16 | Metastases to lymph nodes |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126229681 | 12622968 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126229681 | 12622968 | Delirium | |
126229681 | 12622968 | Drug ineffective | |
126229681 | 12622968 | Drug interaction | |
126229681 | 12622968 | Hypotension | |
126229681 | 12622968 | Respiratory depression | |
126229681 | 12622968 | Toxicity to various agents | |
126229681 | 12622968 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |